poster

Utilization of High Sensitivity Proteomics NULISA HT Panels for Clinical Biomarker Profiling: Assay Qualification and Regulatory Consideration

This first-ever reported study demonstrates the rigorous qualification of NULISAseq high-throughput (HT) panels for clinical biomarker profiling across multiple biomatrices—highlighting Frontage’s leadership in delivering high-sensitivity, multiplexed, and regulatory-ready biomarker assay solutions.